高级检索
    吴一龙, 陆舜, 程颖, 周清华, 王长利, 王绿化, 黄诚, 韩宝惠, 宋启斌, 陈晓媛, 刘安文, 范云, 陈明, 刘伦旭, 陈椿, 宋勇, 董晓荣, 揣少坤, 汪笑男, 易鑫, 严令华, 王维锋, 朱冠山, 张绪超, 杨帆, 钟文昭, 闫小龙, 徐松涛, 刘志刚, 袁智勇, 谢聪颖, 朱波, 崔久嵬, 柳菁菁, 杨衿记, 周清, 杨学宁, 张嘉涛, 中国抗癌协会肺癌专业委员会, 广东省临床试验协会/中国胸部肿瘤研究协作组. 非小细胞肺癌分子残留病灶专家共识[J]. 循证医学, 2021, 21(3): 129-135. DOI: 10.12019/j.issn.1671-5144.2021.03.001
    引用本文: 吴一龙, 陆舜, 程颖, 周清华, 王长利, 王绿化, 黄诚, 韩宝惠, 宋启斌, 陈晓媛, 刘安文, 范云, 陈明, 刘伦旭, 陈椿, 宋勇, 董晓荣, 揣少坤, 汪笑男, 易鑫, 严令华, 王维锋, 朱冠山, 张绪超, 杨帆, 钟文昭, 闫小龙, 徐松涛, 刘志刚, 袁智勇, 谢聪颖, 朱波, 崔久嵬, 柳菁菁, 杨衿记, 周清, 杨学宁, 张嘉涛, 中国抗癌协会肺癌专业委员会, 广东省临床试验协会/中国胸部肿瘤研究协作组. 非小细胞肺癌分子残留病灶专家共识[J]. 循证医学, 2021, 21(3): 129-135. DOI: 10.12019/j.issn.1671-5144.2021.03.001
    shu
    WU Yi-long, LU Shun, CHENG Ying, ZHOU Qing-hua, WANG Chang-li, WANG Lv-hua, HUANG Cheng, HAN Bao-hui, SONG Qi-bin, CHEN Xiao-yuan, LIU An-wen, FAN Yun, CHEN Ming, LIU Lun-xu, CHEN Chun, SONG Yong, DONG Xiao-rong, CHUAI Shao-kun, WANG Xiao-nan, YI Xin, YAN Ling-hua, WANG Wei-feng, ZHU Guan-shan, ZHANG Xu-chao, YANG Fan, ZHONG Wen-zhao, YAN Xiao-long, XU Song-tao, LIU Zhi-gang, YUAN Zhi-yong, XIE Cong-ying, ZHU Bo, CUI Jiu-wei, LIU Jing-jing, YANG Jin-ji, ZHOU Qing, YANG Xue-ning, ZHANG Jia-tao, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials （GACT）/Chinese Thoracic Oncology Group（C-TONG）. Expert Consensus of Molecular Residual Disease for Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2021, 21(3): 129-135. DOI: 10.12019/j.issn.1671-5144.2021.03.001
    Citation: WU Yi-long, LU Shun, CHENG Ying, ZHOU Qing-hua, WANG Chang-li, WANG Lv-hua, HUANG Cheng, HAN Bao-hui, SONG Qi-bin, CHEN Xiao-yuan, LIU An-wen, FAN Yun, CHEN Ming, LIU Lun-xu, CHEN Chun, SONG Yong, DONG Xiao-rong, CHUAI Shao-kun, WANG Xiao-nan, YI Xin, YAN Ling-hua, WANG Wei-feng, ZHU Guan-shan, ZHANG Xu-chao, YANG Fan, ZHONG Wen-zhao, YAN Xiao-long, XU Song-tao, LIU Zhi-gang, YUAN Zhi-yong, XIE Cong-ying, ZHU Bo, CUI Jiu-wei, LIU Jing-jing, YANG Jin-ji, ZHOU Qing, YANG Xue-ning, ZHANG Jia-tao, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials （GACT）/Chinese Thoracic Oncology Group（C-TONG）. Expert Consensus of Molecular Residual Disease for Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2021, 21(3): 129-135. DOI: 10.12019/j.issn.1671-5144.2021.03.001
    shu

    非小细胞肺癌分子残留病灶专家共识

    Expert Consensus of Molecular Residual Disease for Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(45)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回